Comparison of Sublingual Misoprostol Versus Lidocaine Spray for Hysteroscopy
Sponsored by Dr. Sami Ulus Children's Hospital
About this trial
Last updated 13 years ago
Study ID
HEK 11/33-21
Status
Completed
Type
Interventional
Phase
N/A
Placebo
No
Accepting
18 to 51 Years
Female
Not accepting
Healthy Volunteers
Trial Timing
Ended 15 years ago
What is this trial about?
Hysteroscopy is an instrument to visualize the interior walls of uterus (womb) and it
enables the doctor to do minor operative procedures. Although it causes little
discomfort, sometimes it may be disturbing for the patient. This pain is usually
perceived during the passage of the instrument through the cervix (neck of the womb). The
investigators would like to minimize this pain by two drugs: Misoprotol and lidocaine
What are the participation requirements?
Inclusion Criteria
- Premenopausal women in the proliferative phase of the menstrual cycle with no contraindication for hysteroscopy
Exclusion Criteria
- vaginal bleeding at the time of the procedure
- known sensitivity to lidocaine (amide group local anesthetics) or prostaglandins
- epilepsy
- significantly impaired respiratory or cardiac conduction functions
- hypertension
- glaucoma
- renal failure
- acute liver disease
- uncontrolled diabetes mellitus
- pregnancy or suspicion of pregnancy
- pelvic inflammatory disease
- cervical operation history
- vaginismus.